Biomea Fusion (BMEA) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $0.84, +0.24% vs the prior close of $0.83.
- Volume 3.11M shares, 1.4x its 50-day average.
- New SEC filings: 8-K (Oct 14, 2026).
- No new insider buys or sales reported since the prior session.
BMEA ends flat (+0.2%) to $0.84. Closed at $0.84, +0.24% vs the prior close of $0.83. Day range $0.80–$0.89, opened at $0.82.
BMEA daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — BMEA ends flat (+0.2%) to $0.84
- Closed at $0.84, +0.24% vs the prior close of $0.83. Day range $0.80–$0.89, opened at $0.82.
- Volume was 3.11M shares, 1.4x its 50-day average of 2.22M.
- Price is -44.1% vs its 50-day average ($1.50) and -40.7% vs its 200-day average ($1.41).
- 52-week range $0.80–$2.24; today's close sits at 2% of that range, 62.6% below the 52-week high.
Oct 14, 2026 — BMEA slides 33.8% to $0.83, a 52-week low on 5.8x normal volume
- Closed at $0.83, -33.81% vs the prior close of $1.26. Day range $0.80–$1.00, opened at $1.00.
- Volume was 11.71M shares, 5.8x its 50-day average of 2.00M — unusually heavy trading.
- Price is -44.6% vs its 50-day average ($1.50) and -40.9% vs its 200-day average ($1.41).
- 52-week range $0.80–$2.24; today's close sits at 2% of that range, 62.7% below the 52-week high.
- That makes 3 straight losses.
- SEC filings that day: 8-K.
Oct 13, 2026 — BMEA slides 7.4% to $1.26 on 4.5x normal volume
- Closed at $1.26, -7.35% vs the prior close of $1.36. Day range $1.23–$1.44, opened at $1.43.
- Volume was 8.32M shares, 4.5x its 50-day average of 1.85M — unusually heavy trading.
- Price is -16.7% vs its 50-day average ($1.51) and -10.9% vs its 200-day average ($1.41).
- 52-week range $0.87–$2.24; today's close sits at 28% of that range, 43.7% below the 52-week high.
Oct 12, 2026 — BMEA slides 4.2% to $1.36 on 3.1x normal volume
- Closed at $1.36, -4.23% vs the prior close of $1.42. Day range $1.36–$1.46, opened at $1.44.
- Volume was 5.37M shares, 3.1x its 50-day average of 1.76M — unusually heavy trading.
- Price is -10.0% vs its 50-day average ($1.51) and -3.9% vs its 200-day average ($1.41).
- 52-week range $0.87–$2.24; today's close sits at 36% of that range, 39.2% below the 52-week high.
Oct 9, 2026 — BMEA jumps 3.6% to $1.42, 3 up days in a row
- Closed at $1.42, +3.65% vs the prior close of $1.37. Day range $1.38–$1.45, opened at $1.38.
- Volume was 1.17M shares, 0.7x its 50-day average of 1.74M.
- Price is -5.8% vs its 50-day average ($1.51) and +0.4% vs its 200-day average ($1.41).
- 52-week range $0.87–$2.24; today's close sits at 40% of that range, 36.5% below the 52-week high.
- That makes 3 straight gains.
Oct 8, 2026 — BMEA jumps 3.8% to $1.37
- Closed at $1.37, +3.79% vs the prior close of $1.32. Day range $1.30–$1.38, opened at $1.32.
- Volume was 1.71M shares, 1.0x its 50-day average of 1.71M.
- Price is -8.8% vs its 50-day average ($1.50) and -3.1% vs its 200-day average ($1.41).
- 52-week range $0.87–$2.24; today's close sits at 36% of that range, 38.8% below the 52-week high.
Oct 7, 2026 — BMEA jumps 5.6% to $1.32
- Closed at $1.32, +5.60% vs the prior close of $1.25. Day range $1.25–$1.34, opened at $1.27.
- Volume was 835.40K shares, 0.5x its 50-day average of 1.71M — lighter than usual.
- Price is -12.0% vs its 50-day average ($1.50) and -6.7% vs its 200-day average ($1.41).
- 52-week range $0.87–$2.24; today's close sits at 33% of that range, 41.0% below the 52-week high.
Oct 6, 2026 — BMEA slides 3.8% to $1.25, a 1-month low
- Closed at $1.25, -3.85% vs the prior close of $1.30. Day range $1.24–$1.31, opened at $1.28.
- Volume was 797.00K shares, 0.5x its 50-day average of 1.70M — lighter than usual.
- Price is -16.6% vs its 50-day average ($1.50) and -11.6% vs its 200-day average ($1.41).
- 52-week range $0.87–$2.99; today's close sits at 18% of that range, 58.2% below the 52-week high.
Oct 5, 2026 — BMEA rises 2.4% to $1.30
- Closed at $1.30, +2.36% vs the prior close of $1.27. Day range $1.22–$1.31, opened at $1.27.
- Volume was 1.04M shares, 0.6x its 50-day average of 1.69M.
- Price is -13.3% vs its 50-day average ($1.50) and -8.1% vs its 200-day average ($1.41).
- 52-week range $0.87–$2.99; today's close sits at 20% of that range, 56.5% below the 52-week high.
Oct 2, 2026 — BMEA dips 2.3% to $1.27
- Closed at $1.27, -2.31% vs the prior close of $1.30. Day range $1.26–$1.30, opened at $1.30.
- Volume was 843.20K shares, 0.5x its 50-day average of 1.68M — lighter than usual.
- Price is -15.2% vs its 50-day average ($1.50) and -10.3% vs its 200-day average ($1.42).
- 52-week range $0.87–$2.99; today's close sits at 19% of that range, 57.5% below the 52-week high.
BMEA latest news & SEC filings
Every SEC filing by or about BMEA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Sep 22, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 5, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$8.33M (prior year -$20.74M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.12 (prior year -$0.51) (loss narrowed vs Jun 30, 2025)
Aug 5, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Exhibits / financial statements only (Item 9.01).
Things to know before you trade BMEA
- Last results release: May 11, 2026 (8-K Item 2.02). Previous ones: Mar 24, 2026, Nov 4, 2025, Aug 5, 2025. Based on that rhythm, the next report is likely around Aug 10, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 5.96% (largest 33.8%). That is a volatile stock.
- Liquidity: about 3.04M shares (≈$2.54M) trade per day on average.
- 52-week position: $0.84 vs a range of $0.80–$2.24 (2% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 4 open-market buys, 0 sales; latest: Rainer M Erdtmann bought 30,000 shares on Dec 11, 2025.
- Latest filings: 8-K Oct 14, 2026; 8-K Sep 22, 2026; 10-Q Aug 5, 2026.
- Share count: 72.48M shares outstanding (Jul 31, 2026), +21.8% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
BMEA market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 0.82 | 0.89 | 0.80 | 0.84 | 3.11M |
| Oct 14, 2026 | 1.00 | 1.00 | 0.80 | 0.83 | 11.71M |
| Oct 13, 2026 | 1.43 | 1.44 | 1.23 | 1.26 | 8.32M |
| Oct 12, 2026 | 1.44 | 1.46 | 1.36 | 1.36 | 5.37M |
| Oct 9, 2026 | 1.38 | 1.45 | 1.38 | 1.42 | 1.17M |
| Oct 8, 2026 | 1.32 | 1.38 | 1.30 | 1.37 | 1.71M |
| Oct 7, 2026 | 1.27 | 1.34 | 1.25 | 1.32 | 835.40K |
| Oct 6, 2026 | 1.28 | 1.31 | 1.24 | 1.25 | 797.00K |
| Oct 5, 2026 | 1.27 | 1.31 | 1.22 | 1.30 | 1.04M |
| Oct 2, 2026 | 1.30 | 1.30 | 1.26 | 1.27 | 843.20K |
| Oct 1, 2026 | 1.32 | 1.36 | 1.30 | 1.30 | 1.07M |
| Sep 30, 2026 | 1.29 | 1.37 | 1.26 | 1.33 | 1.45M |
| Sep 29, 2026 | 1.28 | 1.30 | 1.25 | 1.26 | 1.56M |
| Sep 28, 2026 | 1.32 | 1.37 | 1.27 | 1.29 | 1.46M |
| Sep 25, 2026 | 1.49 | 1.49 | 1.30 | 1.32 | 3.08M |
| Sep 24, 2026 | 1.46 | 1.50 | 1.39 | 1.49 | 2.18M |
| Sep 23, 2026 | 1.70 | 1.72 | 1.35 | 1.44 | 9.30M |
| Sep 22, 2026 | 1.71 | 1.78 | 1.66 | 1.70 | 2.34M |
| Sep 21, 2026 | 1.84 | 1.85 | 1.67 | 1.71 | 1.78M |
| Sep 18, 2026 | 1.79 | 1.93 | 1.77 | 1.83 | 1.63M |
About Biomea Fusion
Biomea Fusion (BMEA) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in SAN CARLOS, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1840439.
BMEA board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Eric Aguiar | Director | Jun 12, 2026 |
| Julianne Averill | Director | Jun 12, 2026 |
| Rainer M Erdtmann | See Remarks | Apr 3, 2026 |
| Elizabeth Faust | Director | Jun 12, 2026 |
| Michael J.M. Hitchcock | Interim CEO | Apr 3, 2026 |
| Sumita Ray | Director | Jun 12, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Rainer M Erdtmann | See Remarks | Apr 3, 2026 |
| Michael J.M. Hitchcock | Interim CEO | Apr 3, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Dec 11, 2025 | Rainer M Erdtmann | Buy | 30,000 | $1.43 |
| Dec 2, 2025 | Michael J.M. Hitchcock | Buy | 100,000 | $0.99 |
| Dec 1, 2025 | Rainer M Erdtmann | Buy | 10,000 | $1.05 |
| Nov 28, 2025 | Rainer M Erdtmann | Buy | 40,000 | $1.10 |
BMEA financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-61.80M | -1.18 | $-70.37M |
| Dec 31, 2024 | — | $-138.43M | -3.83 | $-119.89M |
| Dec 31, 2023 | — | $-117.25M | -3.44 | $-96.59M |
| Dec 31, 2022 | — | $-81.83M | -2.80 | $-62.42M |
| Dec 31, 2021 | — | $-41.57M | -1.74 | $-35.44M |
Latest balance sheet: total assets $36.87M, total liabilities $24.74M, cash $34.82M (as of Jun 30, 2026).
BMEA earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| May 11, 2026 | 8-K Item 2.02 (results) | $1.57 |
| Mar 24, 2026 | 8-K Item 2.02 (results) | $1.13 |
| Nov 4, 2025 | 8-K Item 2.02 (results) | $1.26 |
| Aug 5, 2025 | 8-K Item 2.02 (results) | $1.58 |
| May 5, 2025 | 8-K Item 2.02 (results) | $2.00 |
| Mar 31, 2025 | 8-K Item 2.02 (results) | $2.13 |
| Oct 29, 2024 | 8-K Item 2.02 (results) | $12.06 |
| Jul 31, 2024 | 8-K Item 2.02 (results) | — |
| May 2, 2024 | 8-K Item 2.02 (results) | — |
| Apr 1, 2024 | 8-K Item 2.02 (results) | — |
| Oct 30, 2023 | 8-K Item 2.02 (results) | — |
| Jul 31, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on BMEA
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.